Twist Bioscience Corporation TWST Change in fair value of contingent consideration
Change in fair value of contingent consideration at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: Twist Bioscience Corporation’s 10-K, filed November 17, 2025, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's change in fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's change in fair value of contingent consideration?
- Twist Bioscience Corporation (TWST) reported change in fair value of contingent consideration of $0 in Q3 2025.
- What is the long-term trend for Twist Bioscience Corporation's change in fair value of contingent consideration?
- Over 2 years (2023 to 2025), Twist Bioscience Corporation's change in fair value of contingent consideration has grown at a -100.0% compound annual growth rate (CAGR), from -$5.91M to $0.
- What does change in fair value of contingent consideration mean?
- Reflects the non-cash adjustment to the fair value of liabilities related to earn-outs or performance-based payments from past acquisitions. Fluctuations in this value indicate changes in the probability or expected magnitude of achieving specific post-acquisition financial or operational milestones.